OriGene Logo
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Home Support Citations




OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.

Search citations by gene symbols or target names

Here are some of the recent papers making use of OriGene products by fellow researchers.

  Page: 1 of 9 

Target Research Paper Journal Product SKU
Parallel reverse genetic screening in mutant human cells using transcriptomics Mol. Syst. Biol. 2016 Transfection TF81001

DNA polymerase ? functions in the generation of tandem mutations during somatic hypermutation of antibody genes J. Exp. Med. 2016 Transfection TF81001

Over-expressed human TREK-1 inhibits CHO cell proliferation via inhibiting PKA and p38 MAPK pathways and subsequently inducing G1 arrest Acta Pharmacol. Sin. 2016 Transfection TT200002

Knockdown of Zinc Transporter ZIP5 by RNA Interference Inhibits Esophageal Cancer Growth In Vivo Oncol. Res. 2016 Transfection TT200002

Suppression of MTHFD2 in MCF7 breast cancer cells increases glycolysis, dependency on exogenous glycine and sensitivity to folate depletion J. Proteome Res. Jun 2016 Transfection TF81001

Endometrial MFG-E8 regulates TGF-ß induced EMT promoting trophoblast invasion and implantation Reproduction Jun 2016 Transfection TF81001

miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway J. Exp. Clin. Cancer Res. Jun 2016 Transfection TF81001

MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin Oncotarget Mar 2016 Transfection TT300001

A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity Nat. Immunol. Mar 2016 Transfection TF81001

Inhibition of adhesion, migration and of a5ß1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A J. Inorg. Biochem. Feb 2016 Transfection TT300001

CH1001 RNA Interference as a Tool to Selectively Down-Modulate Protein Function Brain Energy Metabolism Jul 2014 Transfection TT100064

HPRT101 Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy Oncogene Jun 2014 Transfection TF81001

HT1001 IL-1ß induces p62/SQSTM1 and represses androgen receptor expression in prostate cancer cells J. Cell. Biochem. Aug 2014 Transfection TT300001

HT1005 Nonviral gene transfer to human meniscal cells. Part I: transfection analyses and cell transplantation to meniscus explants Int Orthop Jun 2014 Transfection TF81001

MEGA TRAN 1.0 The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration Nucleic Acids Res., Sep 2010; 38: 5542 - 5553 Transfection

MEGATRAN Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer Mol. Cancer Ther., Jan 2013; 12: 58 - 68. Transfection TT200002

MEGATRAN 1.0 CHAC2, downregulated in gastric and colorectal cancers, acted as a tumor suppressor inducing apoptosis and autophagy through unfolded protein response Cell Death Dis 2017 Transfection TT200003

MEGATRAN 1.0 MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling Oncol Lett 2017 Transfection TT200003

MEGATRAN 1.0 Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9 PLoS ONE 2017 Transfection TT200003

MEGATRAN 1.0 Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer. Eur. J. Cell Biol. 2017 Transfection TT200002


Inc 5000 Healthcare Company